Covovax Coronavirus Vaccines India
-
{
- All
- News
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
- Wednesday January 18, 2023
- India News | Press Trust of India
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
www.ndtv.com
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
- Thursday January 12, 2023
- India News | Press Trust of India
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
www.ndtv.com
-
"Covovax Trials Finally Begin In India," Tweets Adar Poonawalla
- Saturday March 27, 2021
- India News | Edited by Swati Bhasin
Adar Poonawalla, CEO of the world's largest vaccine manufacturer Serum Institute of India, today said trials in India have started for Covovax - the coronavirus vaccine being developed in partnership with American vaccine developer Novavax.
-
www.ndtv.com
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
- Wednesday January 18, 2023
- India News | Press Trust of India
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
www.ndtv.com
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
- Thursday January 12, 2023
- India News | Press Trust of India
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
www.ndtv.com
-
"Covovax Trials Finally Begin In India," Tweets Adar Poonawalla
- Saturday March 27, 2021
- India News | Edited by Swati Bhasin
Adar Poonawalla, CEO of the world's largest vaccine manufacturer Serum Institute of India, today said trials in India have started for Covovax - the coronavirus vaccine being developed in partnership with American vaccine developer Novavax.
-
www.ndtv.com